Position in UTHR
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$3,368,556
+$1,024 QoQ
Shares Held
6,217
+9.5% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#297
of 874 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TRUIST FINANCIAL CORP holds $42,596,492 across 20 Drug Manufacturers - Specialty & Generic names. UTHR ranks #4 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
392,480 | $13,297,221 | |
| 2 | ZTS |
Zoetis Inc.
|
116,123 | $8,344,597 | |
| 3 | HLN |
Haleon plc
|
504,080 | $4,703,065 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
6,217 | $3,368,556 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
51,671 | $3,304,360 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
17,951 | $3,025,461 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
71,842 | $1,151,626 | |
| 8 | VTRS |
Viatris Inc
|
61,364 | $974,459 |
All Filings in UTHR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,368,556 | 6,217 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $3,367,532 | 5,679 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $2,752,474 | 5,649 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $2,368,117 | 5,649 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,459,737 | 5,080 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $1,574,642 | 5,108 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,777,254 | 5,037 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $2,851,390 | 7,957 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,752,270 | 8,640 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $2,144,204 | 9,334 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,376,569 | 10,808 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $2,781,136 | 12,313 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,424,057 | 6,451 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $1,148,690 | 5,129 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $1,787,562 | 6,428 | Shares | Defined | 2023-02-17 | |
| 2022-09-30 | $1,367,668 | 6,532 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $1,200,820 | 5,096 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $684,448 | 3,815 | Shares | Defined | 2022-04-22 | |
| 2021-12-31 | $2,164,904 | 10,019 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,750,554 | 9,484 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $1,365,667 | 7,612 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $230,162 | 1,376 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $997,106 | 6,569 | Shares | Defined | 2021-11-19 | |
| No filing history on record for this holder in this stock. | ||||||